Endovia Health Sciences, Inc. earnings releases EDVA

Endovia Health Sciences, Inc. last reported quarterly results on Aug 20, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $0 (+100.0% year over year) and diluted EPS of -$0.67. It usually reports 47–51 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 17, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 47–51 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 20, 2026
51 days after quarter end
Q2 FY2026
ended Jun 30, 2026
0
+100.0%
-2
+75.8%
-0.67
+96.3%
Aug 16, 2023
47 days after quarter end
—
ended Jun 30, 2023
—
—
—
Nov 17, 2022
48 days after quarter end
—
ended Sep 30, 2022
—
—
—
Aug 16, 2022
47 days after quarter end
—
ended Jun 30, 2022
—
—
—
Apr 1, 2022
1 days after quarter end
—
ended Mar 31, 2022
—
—
—
Nov 17, 2021
48 days after quarter end
—
ended Sep 30, 2021
—
—
—
Aug 18, 2021
49 days after quarter end
—
ended Jun 30, 2021
—
—
—
May 14, 2021
44 days after quarter end
—
ended Mar 31, 2021
—
—
—

Company profile

Industry
Beverages (SIC 2080)
Listed as
EDVA (NYSE)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Fort Lauderdale, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1553788
Former names
SPLASH BEVERAGE GROUP, INC. (until Aug 21, 2026); Canfield Medical Supply, Inc. (until Aug 5, 2020)

Other Beverages companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.